Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10078741rdf:typepubmed:Citationlld:pubmed
pubmed-article:10078741lifeskim:mentionsumls-concept:C0007758lld:lifeskim
pubmed-article:10078741lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:10078741lifeskim:mentionsumls-concept:C0017785lld:lifeskim
pubmed-article:10078741pubmed:issue4lld:pubmed
pubmed-article:10078741pubmed:dateCreated1999-4-30lld:pubmed
pubmed-article:10078741pubmed:abstractTextDegenerative cerebellar ataxia with autoantibodies against glutamic acid decarboxylase (GAD) is a rare disorder and may represent a subset of ataxias previously classified as idiopathic. The authors report a patient with progressive cerebellar ataxia, insulin-dependent diabetes mellitus, and GAD antibodies who responded to i.v. immunoglobulins.lld:pubmed
pubmed-article:10078741pubmed:languageenglld:pubmed
pubmed-article:10078741pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10078741pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10078741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10078741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10078741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10078741pubmed:statusMEDLINElld:pubmed
pubmed-article:10078741pubmed:monthMarlld:pubmed
pubmed-article:10078741pubmed:issn0028-3878lld:pubmed
pubmed-article:10078741pubmed:authorpubmed-author:WellerMMlld:pubmed
pubmed-article:10078741pubmed:authorpubmed-author:AbeleMMlld:pubmed
pubmed-article:10078741pubmed:authorpubmed-author:DichgansJJlld:pubmed
pubmed-article:10078741pubmed:authorpubmed-author:KlockgetherTTlld:pubmed
pubmed-article:10078741pubmed:authorpubmed-author:GarbRRlld:pubmed
pubmed-article:10078741pubmed:authorpubmed-author:MescheriakovS...lld:pubmed
pubmed-article:10078741pubmed:issnTypePrintlld:pubmed
pubmed-article:10078741pubmed:day10lld:pubmed
pubmed-article:10078741pubmed:volume52lld:pubmed
pubmed-article:10078741pubmed:ownerNLMlld:pubmed
pubmed-article:10078741pubmed:authorsCompleteYlld:pubmed
pubmed-article:10078741pubmed:pagination857-9lld:pubmed
pubmed-article:10078741pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10078741pubmed:meshHeadingpubmed-meshheading:10078741...lld:pubmed
pubmed-article:10078741pubmed:meshHeadingpubmed-meshheading:10078741...lld:pubmed
pubmed-article:10078741pubmed:meshHeadingpubmed-meshheading:10078741...lld:pubmed
pubmed-article:10078741pubmed:meshHeadingpubmed-meshheading:10078741...lld:pubmed
pubmed-article:10078741pubmed:meshHeadingpubmed-meshheading:10078741...lld:pubmed
pubmed-article:10078741pubmed:meshHeadingpubmed-meshheading:10078741...lld:pubmed
pubmed-article:10078741pubmed:meshHeadingpubmed-meshheading:10078741...lld:pubmed
pubmed-article:10078741pubmed:year1999lld:pubmed
pubmed-article:10078741pubmed:articleTitleCerebellar ataxia with glutamic acid decarboxylase autoantibodies.lld:pubmed
pubmed-article:10078741pubmed:affiliationDepartment of Neurology, University of Tübingen, Germany. michael.abele@uni-bonn.delld:pubmed
pubmed-article:10078741pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10078741pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10078741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10078741lld:pubmed